M-C Verdier
Overview
Explore the profile of M-C Verdier including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
53
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Tattevin P, Dinh A, Ghout I, Mouton W, Verdier M, Laurent F, et al.
Int J Antimicrob Agents
. 2020 Sep;
56(5):106152.
PMID: 32898684
Guidelines for the management of carbapenemase-producing Enterobacterales (CPE) infections recommend a combination of two active agents, including meropenem if the minimum inhibitory concentration (MIC) is ≤8 mg/L. The therapeutic equivalence...
2.
Lorne E, Nuzzo D, Suzanne S, Walczak K, Perret C, Laigle C, et al.
Anaesth Crit Care Pain Med
. 2018 Dec;
37(6):653.
PMID: 30573210
No abstract available.
3.
Boglione-Kerrien C, Picard S, Tron C, Nimubona S, Gangneux J, Lalanne S, et al.
J Cancer Res Clin Oncol
. 2017 Sep;
144(1):127-134.
PMID: 28932906
Purpose: Posaconazole is a triazole antifungal widely used for prophylaxis of invasive fungal disease (IFI). Posaconazole tablets allow reaching higher plasma levels than the oral suspension, but safety data with...
4.
Petitcollin A, Boglione-Kerrien C, Tron C, Nimubona S, Lalanne S, Lemaitre F, et al.
Antimicrob Agents Chemother
. 2017 Aug;
61(11).
PMID: 28848009
Posaconazole is extensively used for prophylaxis for invasive fungal infections. The gastro-resistant tablet formulation has allowed the bioavailability issues encountered with the oral suspension to be overcome. However, overexposure is...
5.
Petitcollin A, Crochette R, Tron C, Verdier M, Boglione-Kerrien C, Vigneau C, et al.
Drug Metab Pharmacokinet
. 2016 Aug;
31(5):389-393.
PMID: 27530708
Being a substrate of the cytochrome P450 3A4 (CYP3A4) isoenzyme, sirolimus metabolism is decreased when posaconazole is administered concomitantly. However, because of the poor bioavailability of the oral suspension of...
6.
Lemaitre F, Jezequel C, Verdier M, Dermu M, Boglione-Kerrien C, Boudjema K, et al.
Transpl Infect Dis
. 2015 Jan;
17(1):106-10.
PMID: 25573697
Telaprevir is a novel NS3A/4A protease inhibitor approved in combination with ribavirin and peg-interferon alfa for the treatment of genotype-1 chronic hepatitis C. This drug is also known to be...
7.
Batail J, Langree B, Robert G, Bleher S, Verdier M, Bellissant E, et al.
Schizophr Res
. 2014 Oct;
159(2-3):411-4.
PMID: 25278103
Schizophrenia is a chronic illness with a progressive course that can be marked by resistance to antipsychotic treatment. This can make therapeutic support challenging for the practitioner, with results that...
8.
Lorne E, Nuzzo D, Suzanne S, Walczak K, Perret C, Laigle C, et al.
Ann Fr Anesth Reanim
. 2012 Jul;
31(10):783-7.
PMID: 22784474
Objective: Storage of cisatracurium at room temperature seems to have no effect on its degradation in vitro contrary to the recommendations of storage at +4°C. The purpose of this study...
9.
Laviolle B, Le Maguet P, Verdier M, Massart C, Donal E, Laine F, et al.
Clin Pharmacol Ther
. 2010 Jul;
88(2):183-90.
PMID: 20631694
Low doses of hydrocortisone (HC) and fludrocortisone (FC) administered together improve the prognosis after septic shock; however, there continues to be disagreement about the utility of FC for this indication....